Portal de Periódicos da CAPES

Metoclopramide, H2 Blockers, and Proton Pump Inhibitors: Pharmacotherapy for Gastroesophageal Reflux in Neonates

2012; Elsevier BV; Volume: 39; Issue: 1 Linguagem: Inglês

10.1016/j.clp.2011.12.015

1557-9840

William Malcolm, C. Michael Cotten,

Intestinal Malrotation and Obstruction Disorders

Pharmacotherapy for gastroesophageal reflux (GER) in neonates, aimed at interfering with this physiologic process and potentially reducing the negative sequelae that providers often attribute to GER, consists primarily of drugs that increase the viscosity of feeds, reduce stomach acidity, or improve gut motility. Medications used to treat clinical signs thought to be from GER, such as apnea, bradycardia, or feeding intolerance, are among the most commonly prescribed medications in neonatal intensive care units in the United States, despite the lack of evidence of safety and efficacy in this population.